American Heart Journal
Volume 159, Issue 3 , Page e13 , March 2010

Reply to the Letter to the Editor by Yi et al

References 

  1. Sutton MG, Plappert T, Hilpisch KE, et al. Sustained reverse left ventricular structural remodeling with cardiac resynchronization at one year is a function of etiology: quantitative Doppler echocardiographic evidence from the Multicenter InSync Randomized Clinical Evaluation (MIRACLE). Circulation. 2006;113:266–272
  2. Wikstrom G, Blomstrom-Lundqvist C, Andren B, et al. The effects of aetiology on outcome in patients treated with cardiac resynchronization therapy in the CARE-HF trial. Eur Heart J. 2009;30:782–788
  3. Marsan NA, Bleeker GB, van Bommel RJ, et al. Comparison of time course of response to cardiac resynchronization therapy in patients with ischemic versus nonischemic cardiomyopathy. Am J Cardiol. 2009;103:690–694
  4. Bleeker GB, Kaandorp TA, Lamb HJ, et al. Effect of posterolateral scar tissue on clinical and echocardiographic improvement after cardiac resynchronization therapy. Circulation. 2006;113:969–976
  5. Ypenburg C, van Bommel RJ, Delgado V, et al. Optimal left ventricular lead position predicts reverse remodeling and survival after cardiac resynchronization therapy. J Am Coll Cardiol. 2008;52:1402–1409

 Disclosures: Professor Bax received grants from Medtronic, Boston Scientific, BMS medical imaging, St. Jude Medical & GE Health care.

PII: S0002-8703(09)00970-3

doi: 10.1016/j.ahj.2009.12.016

American Heart Journal
Volume 159, Issue 3 , Page e13 , March 2010

Article Tools